Nathan Weaver Sells 9,561 Shares of H. B. Fuller (NYSE:FUL) Stock

H. B. Fuller Company (NYSE:FUL) VP Nathan Weaver sold 9,561 shares of the business’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $62.06, for a total value of $593,355.66. Following the sale, the vice president owned 11,739 shares in the company, valued at approximately $728,522.34. This trade represents a 44.89% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

H. B. Fuller Stock Up 0.1%

Shares of NYSE FUL opened at $60.24 on Friday. The company has a 50 day simple moving average of $59.30 and a 200 day simple moving average of $60.48. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.80 and a quick ratio of 1.12. H. B. Fuller Company has a 1 year low of $48.71 and a 1 year high of $68.63. The firm has a market cap of $3.24 billion, a PE ratio of 18.48, a price-to-earnings-growth ratio of 0.65 and a beta of 0.98.

H. B. Fuller (NYSE:FUL) last posted its earnings results on Thursday, June 25th. The specialty chemicals company reported $1.41 earnings per share for the quarter, topping analysts’ consensus estimates of $1.37 by $0.04. The firm had revenue of $950.27 million for the quarter, compared to analyst estimates of $924.83 million. H. B. Fuller had a net margin of 5.29% and a return on equity of 12.18%. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.18 EPS. On average, research analysts forecast that H. B. Fuller Company will post 4.87 EPS for the current year.

H. B. Fuller Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, August 13th. Investors of record on Thursday, July 30th were given a dividend of $0.245 per share. This represents a $0.98 annualized dividend and a yield of 1.6%. The ex-dividend date of this dividend was Thursday, July 30th. H. B. Fuller’s dividend payout ratio (DPR) is currently 30.06%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on FUL shares. The Goldman Sachs Group set a $67.00 price target on H. B. Fuller in a research report on Friday, June 26th. UBS Group set a $69.00 price objective on H. B. Fuller in a research note on Friday, June 26th. Deutsche Bank Aktiengesellschaft upped their target price on H. B. Fuller from $70.00 to $72.00 and gave the company a “buy” rating in a report on Tuesday, June 30th. Wall Street Zen lowered shares of H. B. Fuller from a “strong-buy” rating to a “buy” rating in a report on Saturday, July 25th. Finally, Citigroup boosted their price target on shares of H. B. Fuller from $70.00 to $75.00 and gave the stock a “buy” rating in a research report on Tuesday, June 30th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $67.86.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Allworth Financial LP grew its stake in H. B. Fuller by 50.1% during the fourth quarter. Allworth Financial LP now owns 578 shares of the specialty chemicals company’s stock worth $34,000 after purchasing an additional 193 shares during the period. Hantz Financial Services Inc. lifted its stake in H. B. Fuller by 432.9% in the fourth quarter. Hantz Financial Services Inc. now owns 778 shares of the specialty chemicals company’s stock valued at $46,000 after buying an additional 632 shares during the period. Aster Capital Management DIFC Ltd bought a new position in shares of H. B. Fuller during the 4th quarter worth approximately $46,000. Torren Management LLC bought a new position in shares of H. B. Fuller during the 4th quarter worth approximately $52,000. Finally, Brown Brothers Harriman & Co. acquired a new stake in shares of H. B. Fuller during the 3rd quarter worth approximately $56,000. 95.93% of the stock is owned by institutional investors and hedge funds.

Key H. B. Fuller News

Here are the key news stories impacting H. B. Fuller this week:

• Positive Sentiment: Ancora Holdings Group, a significant FUL shareholder, submitted an unsolicited cash offer for the BAS business. A transaction at the proposed valuation could generate substantial proceeds for H. B. Fuller, potentially supporting debt reduction, shareholder returns or investment in higher-growth operations. Reuters article
• Positive Sentiment: H. B. Fuller confirmed receipt of the proposal, raising the possibility of negotiations, a strategic review or competing interest that could result in a higher valuation for BAS. The offer also suggests Ancora believes the segment is worth more than its current contribution to FUL’s market value. H.B. Fuller proposal confirmation
• Positive Sentiment: Shareholders of Advanced Medical Solutions Group approved resolutions related to H. B. Fuller’s cash takeover of the medical-products company, indicating progress on FUL’s broader portfolio expansion strategy. Advanced Medical Solutions shareholder vote
• Neutral Sentiment: Recent valuation commentary argues that FUL may be undervalued, supported by its earnings outlook and a reported price-to-earnings-growth ratio below 1. Its latest quarterly results also showed EPS and revenue above consensus, with revenue up 5.8% year over year, providing fundamental support for the shares. Zacks valuation analysis
• Negative Sentiment: The BAS offer is unsolicited, nonbinding and may not lead to a deal. Divesting the segment could also reduce H. B. Fuller’s scale and earnings diversification, while activist pressure may create uncertainty over management’s strategy and debt plans. Ancora proposal letter
• Negative Sentiment: Vice President Nathan Weaver sold 9,561 shares valued at approximately $593,000, reducing his direct ownership by nearly 45%. Although a single insider sale is not conclusive, it could modestly weigh on investor sentiment. SEC insider transaction filing

About H. B. Fuller

H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.

Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.